Deqing Xiao

853 total citations
31 papers, 680 citations indexed

About

Deqing Xiao is a scholar working on Infectious Diseases, Oncology and Pharmacology. According to data from OpenAlex, Deqing Xiao has authored 31 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Deqing Xiao's work include Drug Transport and Resistance Mechanisms (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and HIV/AIDS drug development and treatment (7 papers). Deqing Xiao is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and HIV/AIDS drug development and treatment (7 papers). Deqing Xiao collaborates with scholars based in United States, Czechia and Switzerland. Deqing Xiao's co-authors include Mary J. Wirth, Hui Zhang, Steven Hansel, Chang Cheng, Shaorong Liu, Thomas Tarnowski, Kah Hiing John Ling, Lili Yao, Polina German and Rita Humeniuk and has published in prestigious journals such as Analytical Chemistry, Macromolecules and Langmuir.

In The Last Decade

Deqing Xiao

27 papers receiving 671 citations

Peers

Countries citing papers authored by Deqing Xiao

Since Specialization

Citations

This map shows the geographic impact of Deqing Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deqing Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deqing Xiao more than expected).

Fields of papers citing papers by Deqing Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deqing Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deqing Xiao. The network helps show where Deqing Xiao may publish in the future.

Co-authorship network of co-authors of Deqing Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Deqing Xiao. A scholar is included among the top collaborators of Deqing Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deqing Xiao. Deqing Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Evaluation of Drug–Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent 2025 ·Clinical Pharmacology & Therapeutics ·(unknown), Rita Humeniuk, (unknown), (unknown), (unknown), (unknown), Deqing Xiao, Shuguang Chen, Santosh Davies, Sharline Madera, (unknown), Amos Lichtman, (unknown), (unknown), Helen Winter, Luzelena Caro	0
2	Characterization of Drug–Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS‐CoV‐2, in Healthy Participants 2025 ·Clinical and Translational Science ·Jack Chang, Aryun Kim, Rita Humeniuk, Abdul Naveed Shaik, Helen Winter, (unknown), Deqing Xiao, Mazin Abdelghany, (unknown), Santosh Davies, (unknown), Shuguang Chen, (unknown), Luzelena Caro	0
3	Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment 2024 ·Clinical Pharmacokinetics ·(unknown), Rita Humeniuk, (unknown), (unknown), Santosh Davies, (unknown), Gong Shen, Deqing Xiao, Robert H. Hyland, Helen Winter, (unknown)	0
4	Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), Mazin Abdelghany, Amos Lichtman, Ran Duan, (unknown), Abdul Naveed Shaik, (unknown), Qin Yue, Raju Subramanian, (unknown), Santosh Davies, (unknown), (unknown), Gong Shen, Deqing Xiao, Luzelena Caro, Helen Winter, (unknown), Rita Humeniuk	3
5	505. Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19 2023 ·Open Forum Infectious Diseases ·(unknown), Mark Shelton, (unknown), (unknown), Deqing Xiao, Shuguang Chen, Sharline Madera, (unknown), Helen Winter, Rita Humeniuk	1
6	Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and Tenofovir Alafenamide 2023 ·Journal of Pharmaceutical Sciences ·(unknown), Ann Qin, Thomas Tarnowski, Kah Hiing John Ling, (unknown), Rita Humeniuk, (unknown), Jovita M. Saquing, Wenbin Liu, (unknown), Deqing Xiao	2
7	Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants 2023 ·Clinical and Translational Science ·Rita Humeniuk, Kavita Juneja, Shuguang Chen, Scott Ellis, (unknown), Deqing Xiao, (unknown), M C Johnston, Santosh Davies, Adam DeZure, (unknown), Anu Osinusi, Helen Winter, Sandhya Girish, (unknown), Mark J. Dresser	5
8	A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV 2023 ·AIDS ·(unknown), Jason T. Hindman, (unknown), (unknown), (unknown), Deqing Xiao, Anchalee Avihingsanon, Priyanka Arora, (unknown), Sandhya Girish, Dhananjay Marathe	16
9	Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist 2023 ·Clinical Pharmacokinetics ·Islam R. Younis, (unknown), Cara Nelson, Brian J. Kirby, (unknown), Deqing Xiao, Timothy R. Watkins, Ahmed A. Othman	2
10	538. Clinical Evaluation of Drug-drug Interactions with Remdesivir 2023 ·Open Forum Infectious Diseases ·(unknown), Mark Shelton, (unknown), (unknown), (unknown), Gong Shen, Deqing Xiao, Aryun Kim, Sharline Madera, Robert H. Hyland, Helen Winter, Rita Humeniuk	0
11	Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist 2023 ·The Journal of Clinical Pharmacology ·Islam R. Younis, Chia‐Hsiang Hsueh, Cara Nelson, Andrew N. Billin, (unknown), Deqing Xiao, Timothy R. Watkins, Ahmed A. Othman	1
12	Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist 2023 ·The Journal of Clinical Pharmacology ·(unknown), Islam R. Younis, Cara Nelson, Dora Ding, Ann Qin, Deqing Xiao, Timothy R. Watkins, Ahmed A. Othman	4
13	The determination of Sulfobutylether β-Cyclodextrin Sodium (SBECD) by LC-MS/MS and its application in remdesivir pharmacokinetics study for pediatric patients 2022 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, Rita Humeniuk, (unknown), (unknown), (unknown), (unknown), (unknown), Quan Cheng	7
14	Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial 2022 ·Transgender Health ·Michelle Cespedes, Moupali Das, (unknown), Maria Prins, Ivanka Krznaric, (unknown), Deqing Xiao, (unknown), Pamela Wong, Alexander Kintu, Christoph C Carter, Elske Hoornenborg, Peter Ruane, (unknown), Islam R. Younis, Jason Halperin	10
15	Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies 2021 ·Analytical Biochemistry ·Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, Rita Humeniuk, Polina German, Anita Mathias, (unknown), (unknown), (unknown)	43
16	An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizer 2020 ·Analytical Biochemistry ·Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, (unknown), Polina German, Brian P. Kearney, Yuwen Zhao, (unknown), Lili Ma, (unknown)	11
17	The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation 2019 ·Analytical Biochemistry ·Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, (unknown), Brian P. Kearney, (unknown), Susan Carr Zondlo	2
18	Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes 2014 ·Drug Metabolism and Disposition ·George Zhang, (unknown), (unknown), R. J. H. Clark, (unknown), (unknown), Deqing Xiao, (unknown), Heidi J. Einolf, David M. Stresser	26
19	Evaluation of Pharmacokinetic/Pharmacodynamic Relationships of PD-0162819, a Biotin Carboxylase Inhibitor Representing a New Class of Antibacterial Compounds, Using In Vitro Infection Models 2011 ·Antimicrobial Agents and Chemotherapy ·Adam Ogden, Michael Kuhn, (unknown), (unknown), (unknown), Tong Zhu, Deqing Xiao, J. Richard Miller, Debra Hanna	3
20	LC–MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma 2010 ·Journal of Chromatography B ·Chang Cheng, Shaorong Liu, Deqing Xiao, (unknown), Lili Yao, (unknown), Steven Hansel	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact